Screener
Privia Health Group, Inc. PRVA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Privia Health Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Privia Health Group, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759655-26-000064
FAQ
- What is Privia Health Group, Inc.'s cash & equivalents?
- Privia Health Group, Inc. (PRVA) reported cash & equivalents of $412.2M in Q2 2026.
- How has Privia Health Group, Inc.'s cash & equivalents changed year-over-year?
- Privia Health Group, Inc.'s cash & equivalents increased by 5.7% year-over-year, from $390.13M to $412.2M.
- What is the long-term trend for Privia Health Group, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Privia Health Group, Inc.'s cash & equivalents has grown at a 41.5% compound annual growth rate (CAGR), from $84.63M to $479.69M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Privia Health Group, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude